Introduction
The ARF tumor suppressor protein (p19 ARF in mouse and p14 ARF in human) is an activator of p53 that antagonizes the function of p53's inhibitor, Mdm2. ARF inhibits Mdm2 by sequestrating it to the nucleolus (Tao and Levine, 1999; Weber et al., 1999) and by inhibiting its E3 protein ubiquitin ligase activity (Honda and Yasuda, 1999; Midgley et al., 2000) . ARF is induced by oncoproteins such as c-Myc (Zindy et al., 1998) , E2F-1 , and b-catenin (Damalas et al., 2001) and is thus an important mediator in the activation of p53 in response to oncogenes (Lowe and Sherr, 2003 ). Yet, the seminal finding that mice lacking p19 ARF , p53, and Mdm2 are more tumor prone than those lacking only p53 and Mdm2 raised the possibility that p19 ARF can also act independently of the Mdm2-p53 axis in tumor surveillance (Weber et al., 2000a) . Consistent with this notion, studies performed in cell culture have shown that the two cellular effects of p19 ARF , i.e., inhibition of cell growth/proliferation and induction of apoptosis, can also occur in a p53-Mdm2-independent manner Nakazawa et al., 2003; Sugimoto et al., 2003; Suzuki et al., 2003; Tsuji et al., 2002) . The inhibitory functions on cellular growth have been associated with inhibition of rRNA processing in the nucleolus via physical interactions with nucleophosmin/B23 Sugimoto et al., 2003 ). Yet, p53-independent molecular mechanisms mediating the prodeath mode of action of p19 ARF have not been thoroughly determined.
The murine p19 ARF is composed of 169 amino acids, is highly basic and hydrophobic, and localizes primarily to nucleoli (Weber et al., 1999) . The human p14 ARF ortholog is composed of only 132 amino acids and shares only limited sequence homology with the mouse protein ). Yet, p14 ARF is also a basic and hydrophobic protein that often localizes predominantly to the nucleolus (Lohrum et al., 2000) , and it retains all known tumor suppressor functions of the mouse p19 ARF protein as well as p19 ARF 's capability to induce p53-independent apoptosis (Hemmati et al., 2002) .
Here we report on a mitochondrial short form of p19 ARF , designated smARF (short mitochondrial ARF), which results from internal initiation of translation. smARF causes dissipation of mitochondrial membrane potential (DJm), in a p53-and Bcl-2-family-independent manner, without releasing cytochrome c. It leads to the induction of massive autophagy and to caspase-independent cell death. Notably, although the mouse and the human ARF mRNA share only limited sequence homology, the ability to produce a shorter protein form is preserved between the orthologs, emphasizing the importance of this ARF isoform.
Results

Internal Initiation of Translation Generates a Short Form of p19 ARF
The murine p19 ARF is composed of 169 amino acids ( Figure 1A ). In addition to the full-length protein, ectopic expression of p19 ARF -Flag cDNA in 293T cells gave rise to a shorter, faster migrating form, which we designated smARF ( Figure 1B ). The levels of smARF corresponded to about 1%-5% of total p19 ARF protein. It should be noted that this form was detected only under gel conditions that efficiently resolved low-molecular-weight proteins, which may explain why smARF has not been previously reported. smARF was detected by Western blotting with either anti-Flag or anti-p19 ARF antibodies (Figures 1B and 1C) , indicating that smARF contains an intact C terminus. It was also present when cells were directly lysed in sample loading buffer ( Figure 1C ), excluding the possibility that smARF is a degradation product generated during the extraction procedure.
One mechanism that may account for the formation of smARF is translation from an internal initiation site. In fact, the p19 ARF mRNA sequence contains a single additional Met at position 45 ( Figure 1A) , which potentially could function as an internal initiation site. Expression of a plasmid in which Met1 was converted to Ile (p19 ARF M1I) resulted in abundant production of a protein product whose electrophoretic mobility was *Correspondence: adi.kimchi@weizmann.ac.il identical to that of smARF, with almost no full-length p19 ARF evident ( Figure 1D ). In contrast, conversion of Met45 to Ile (p19 ARF M45I) abolished almost completely the presence of smARF, even though full-length p19 ARF was produced efficiently ( Figure 1D ). As expected, substitution of both Met1 and Met45 by Ile abolished the expression of both isoforms (data not shown). Deletion of the first 40 amino acids of p19 ARF generated a protein product with the same gel migration profile as the product of M1I (DNp19 ARF , Figure 1D ). In vitro translation in reticulocyte lysates further confirmed the existence of internal translation initiation. In vitro translation from the full-length p19 ARF mRNA gave rise to two protein products. The shorter form had the same electrophoretic mobility on gels as the translation product of the DNp19 ARF plasmid ( Figure 1E , right panel) and as protein product expressed from this plasmid in transfected cells (compare left to right panel in Figure 1E ). Interestingly, in the in vitro reaction, both proteins were produced in equal proportions, suggesting that translation from the second Met is as efficient as from the first. However, in vivo, the short form comprises only a small fraction of the total. Thus, there must be additional regulatory mechanisms that influence translation rates or protein stability in vivo. A plasmid in which Met45 was converted to Ala (M45A) failed to produce smARF upon in vitro translation (data not shown). Taken together, the data suggest that the p19 ARF open reading frame contains two initiation sites and that the primary mechanism for smARF production is internal initiation of translation at Met45.
This short form was also endogenously expressed in nontransfected cells. As shown in Figure 1F , the antip19 ARF antibodies recognized a short p19 ARF form that was present at low levels (compared to the full-length protein) in cells under steady-state growth conditions. This band was apparent in primary and immortalized mouse embryonic fibroblasts (i.e., in early passage [P2] of wt MEF cultures and in 35-8 cells that are MEFderived immortalized cells that lack p53) but not in NIH3T3 cells which lack the INK4A/ARF locus. As expected, the electrophoretic mobility of the endogenous smARF was a bit faster than that of the recombinant Flag-tagged smARF (compare Figures 1C and 1F ; the common nonspecific band can be used as an internal size reference).
Notably, smARF levels were elevated in response to ectopic expression of viral and cellular oncogenes. In SV40-transformed mouse embryonic fibroblasts, the expression of smARF increased more than 10-fold (Figure 1F , right panel). Additionally, introduction of two cellular oncoproteins, E2F-1 and c-Myc, into p53 null primary MEFs (P5) or into the 35-8 cell line led to an increase in smARF protein levels of 1.5-to 3-fold ( Figure 1G ). This moderate yet reproducible increase was also detected at the level of the p19 ARF full-length protein, consistent with previous reports Zindy et al., 1998) . Thus, the two isoforms of p19 ARF are subjected to upregulation in response to hyperproliferative signals of cellular and viral oncogenes.
smARF Is a Short-Lived Protein that Is Degraded by the Proteasome We next examined whether the relative low steady-state levels of smARF are due to differences in the protein turnover. To this end, the stability of the two p19 ARF forms following administration of cycloheximide was measured in the 35-8 cells. Notably, after as little as 10 min, smARF protein expression levels were already reduced, while the full-length p19 ARF protein expression levels remained almost unchanged even after several hours of cycloheximide treatment (Figure 2A ). Thus, smARF is a short-lived protein with a half-life of less than 1 hr, in contrast to the much more stable full-length p19 ARF , which has been reported to display a half-life of w6 hr (Kuo et al., 2004) . Furthermore, the proteasome inhibitor MG132 significantly inhibited the turnover of smARF ( Figure 2B ), indicating that smARF's low steadystate levels are maintained by proteasome-mediated degradation. The significant difference in the turnover rates of the two translational products of ARF may explain why the ratio of smARF to full-length p19
ARF is much lower in cells than in in vitro translation systems.
Of note, in the SV40-transformed fibroblasts shown in Figure 1F , the half-life of smARF was 2-fold greater than in the p53 null fibroblasts (data not shown).
The Human p14
ARF mRNA Also Produces a Shorter Unstable Protein that Is Translated from an Internal ATG The human ARF mRNA also contains an internal Met at position 48 ( Figure 3A ). In fact, in vitro translation of wt p14 ARF in reticulocyte lysate gave rise to two protein products, the first corresponding to the full-length protein and the second to a faster migrating protein designated hsmARF (human smARF) that might correspond to translation initiation from Met 48 ( Figure 3B ). In vitro translation of a plasmid in which Met 1 was converted to Ala resulted in production of a protein product whose electrophoretic mobility was identical to that of hsmARF, with almost no full-length p14 ARF evident ( Figure 3B ). In contrast, conversion of Met 48 to Ala significantly reduced the expression of hsmARF (data not shown). However, hsmARF was barely detectable in 293T cells upon transfection with the wt p14 ARF plasmid, unless the proteasome inhibitor MG132 was added. Remarkably, after 17 hr of treatment with MG132, steadystate levels of hsmARF approached those of the full-length p14 ARF ( Figures 3C and 3D ). These results indicate that the hsmARF's rapid turnover is mediated by the proteasome, even more efficiently than the murine smARF. hsmARF was detected by Western blotting with either anti-Flag ( Figures 3C and 3D ) or anti-p14 ARF antibodies (data not shown), indicating that it contains an intact C terminus. As expected, expression of a p14 M1A plasmid in MG132-treated 293T cells resulted in abundant production of a protein product whose electrophoretic mobility was identical to that of hsmARF, with almost no full-length p14 ARF evident. Thus, the production and controlled degradation of a short, internally initiated translation product are conserved properties of both the murine p19ARF and human p14 ARF orthologs. This feature is not limited to human and mouse; the rat p19 ARF , which we cloned and expressed in 293T cells, ARF antibody on 12% SDS-PAGE. (B) Cells were treated with both cycloheximide and the proteasome inhibitor MG132 (100 mM) for the indicated times. Cell lysates were analyzed as described for (A).
also produced a short form that was readily detectable only upon proteasome inhibition ( Figure 3E ).
smARF Localizes to Mitochondria
Two segments of p19 ARF , namely residues 1-14 and 26-37, have been shown to be critical for the established functions of p19 ARF , i.e., nucleolar localization, Mdm2 binding, and p53-dependent cell cycle arrest (Weber et al., 2000b ) (see also Figure 1A ). Additionally, the first 14 amino acids were recently shown to be essential for ARF-mediated inhibition of ribosomal RNA processing (Sugimoto et al., 2003) , most probably through interaction with nucleophosmin/B23 Itahana et al., 2003) . Since smARF lacks all these important functional domains, it may localize to other cellular compartments and function differently. To determine the localization of smARF, HeLa cells were transiently transfected with p19 ARF M1I, which mainly expresses smARF, and were immunostained with anti-Flag antibodies. Surprisingly, all transfected cells exhibited strong punctate cytoplasmic staining, and in most of the transfectants (>75%), no nucleolar staining was evident ( Figure 4A , upper panels). To determine the nature of the punctate staining, the p19 ARF M1I plasmid was cotransfected with the Mito-DsRed plasmid, which targets a red fluorescent protein specifically to the mitochondria due to its fusion with a mitochondrial targeting sequence. A perfect overlap between the anti-Flag staining and the Mito-DsRed signal was observed ( Figure 4A ), indicating that smARF localizes to mitochondria. smARF mitochondrial localization was also confirmed by confocal microscopy (data not shown). Notably, while HeLa cells cotransfected with luciferase, GFP, and MitoDsRed plasmids exhibited the typical spread and tubular morphology of mitochondria ( Figure 4A , lower panels), the morphology of the mitochondria in cells expressing smARF was abnormal; they were condensed, rounded, and clustered in the perinuclear region (Figure 4A ). To confirm that the endogenous smARF detected at low levels in 35-8 MEFs (see Figure 1F ) also localizes to the mitochondria, these cells were costained with anti-p19 ARF and anti-cytochrome c antibodies. Significantly, positive mitochondrial staining could be detected in a small fraction of the cells, in addition to the expected, much more prominent nucleolar staining of the full-length protein ( Figure 4B ). The staining was specific since no mitochondrial staining could be detected with the same antibodies in NIH3T3 cells that do not express any p19 ARF ( Figure 4B ). In order to confirm the mitochondrial localization of smARF by another approach, mitochondria were separated from the nuclear and cytosolic fractions by differential centrifugation. The biochemical cell fractionations were performed in 35-8 cells to assess endogenous proteins and in 293T cells transfected with DNp19
ARF to assess ectopically expressed smARF; p19 ARF M45A was used as a control. Proteinase K, a nonspecific serine protease that cannot penetrate mitochondrial membranes, was used to determine whether smARF is present inside the mitochondria or associates with the outer surface of the organelle. Both endogenous and exogenous smARF were detected predominantly in the Proteinase K-resistant compartment of the mitochondria ( Figures 4C and 4D ). smARF was subjected to degradation upon addition of the detergent Triton-X ( Figure 4D ). This pattern of resistance to Proteinase K was similar to that of cytochrome c ( Figure 4D , left bottom lane), suggesting that smARF is an intramitochondrial protein. In contrast, Bcl-XL and Bcl-2, which are surface mitochondrial proteins, were completely exposed to Proteinase K even in the absence of detergent and therefore were completely proteolyzed ( Figure 4D , right lanes). Of note, a minor portion of full-length p19 ARF was present in the mitochondrial preparations ( Figure 4C ) and, in contrast to smARF, was sensitive to Proteinase K digestion (w80% digestion, Figure 4D ). Therefore, it is possible that the presence of full-length p19
ARF reflects nonspecific contamination of the mitochondrial fraction, ARF and mutant p14 ARF M1A plasmids were subjected to an in vitro transcription/translation reaction, followed by immunoprecipitation with M2-Flag beads. The proteins were separated by 15% SDS-PAGE. Western blot analysis was carried out using anti-Flag antibodies. (C) 293T cells ectopically expressing p14 ARF were treated with 10 mM MG132 for the indicated times, and lysates were subjected to Western blot analysis on 15% gels with anti-Flag antibodies. (D) 293T cells ectopically expressing wt p14 ARF or mutant p14 ARF M1A plasmids were treated with DMSO or 10 mM MG132 for 17 hr. Cell lysates were analyzed as described for (C). (E) 293T cells ectopically expressing rat p19 ARF were treated with 10 mM MG132 for 17 hr. Proteins were separated by 15% SDS-PAGE and blotted to a nitrocellulose membrane, followed by probing with anti-Flag antibodies. Shown are two different exposures of the same blot in order to clearly visualize both full-length rat p19 ARF and rsmARF. Figure 5A ). Unlike the DNp19
ARF -expressing cells, the adjacent nontransfected cells displayed the typical spread and tubular morphology of mitochondria. These observations suggested that smARF not only impairs the structure of the mitochondria but also dramatically dissipates DJm. These data were compared to the outcome of transfections with the wt p19 ARF plasmid, which expresses high levels of full-length p19 ARF and small amounts of smARF. As expected, most of the cells displayed the typical p19 ARF nucleolar staining and strong MitoTracker staining, suggesting that DJm in these transfectants was not impaired ( Figure 5A ). Yet, in a small fraction of the transfected cells, mainly those displaying the highest p19 ARF expression levels, extranuclear staining was evident in addition to the nucleolar distribution; in some of those cells, MitoTracker uptake was reduced ( Figure 5A ). This further supports the conclusion that the mitochondrial presence of smARF causes dissipation of DJm. Figure 5B ARF . An intermediate phenotype (30%) was observed with the wt p19 ARF plasmid, which is capable of producing both forms. Thus, these experiments imply that smARF, but not full-length p19 ARF , is capable of mediating the reduction in DJm and that the ectopically expressed smARF has to exceed some threshold levels in order to damage the mitochondria. To confirm that the loss of MitoTracker Red staining was in fact a result of smARF-mediated reduction in DJm, flow cytometric analysis of transfected NIH3T3 cells stained with the mitochondrial probe DiOC 6 was performed. FACS analysis was performed on the entire cell population (w50% transfection efficiency). smARF caused a complete loss of DJm in 39.1% of the total cells (i.e., in most of the transfectants) ( Figure 5C ). Thus, two independent experimental methods prove that smARF induces dissipation of the DJm. Despite loss of DJm at 24 hr, cytochrome c was not released from the mitochondria in the majority of cells (Figure 5D ), indicating that the outer mitochondrial membrane was intact. Notably, hsmARF was also detected in the mitochondria and caused dissipation of the DJm (data not shown).
smARF Damages DJm in a p53-and Bcl-2-Independent Manner In order to test whether smARF's function is coupled to the known mitochondrial signaling pathways that involve p53 and the Bcl-2 family proteins, the mitochondrial effect of smARF was assessed in the presence and absence of these regulators. It was found that smARF was also capable of reducing the DJm in the 35-8 MEF-derived cell line that is p53 deficient (Figure 5E ), indicating that p53 is not required for the mitochondrial effects of this p19 ARF form. Introduction of DNp19 ARF into Bax/Bak double null MEFs likewise resulted in dissipation of DJm ( Figure 5E ). Furthermore, smARF's ability to dissipate DJm was not impaired by overexpressing either Bcl-2 or Bcl-XL ( Figure 5F ). This indicates that smARF damages the mitochondrial membrane in a manner that involves neither p53 nor the Bcl-2 family.
smARF Induces Autophagy and CaspaseIndependent Cell Death In order to assess the cellular outcome of smARF expression, 293T cells were transfected with DNp19 ARF and were further analyzed at 48 hr. Cells transfected with control plasmid reached near confluency (Figure 6A) . In contrast, culture dishes transfected with DNp19 ARF contained many rounded, floating, dying cells, similar to cultures that were transfected with TNFR-1 (p55 tumor necrosis factor receptor-1), which triggers typical caspase-dependent cell death (Figure 6A) . The drop in cell survival in response to DNp19 ARF transfection was further quantified at 72 hr and compared to the outcome of transfection with TNFR-1. Two independent viability assays were used, the Neutral Red dye uptake assay and a second sensitive assay that measures cellular luciferase activity in viable cells. As shown in Figure 6B , smARF reduced cell viability to a similar extent as TNFR-1. In parallel, the extent of cell death was directly measured by trypan blue staining. A significant increase in the percent of trypan blue-positive cells was observed in DNp19 ARF transfectants, similar to the extent of cell death induced by TNFR-1 ( Figure 6B, right panel) . Yet, molecular analysis revealed that the type of cell death is different in each case. Western blot analysis of PARP-1 and caspase-3 cleavage confirmed that TNFR-1 induced classical apoptotic cell death involving caspase activation (Figure 6C) . smARF, in contrast, induced caspase-independent cell death, which was not accompanied by PARP-1 or caspase-3 cleavage ( Figure 6C ) and which was not blocked by the pancaspase inhibitor zVAD-fmk (data not shown). Although mitochondrial function was impaired by smARF ( Figure 5 ), ATP production was maintained in these cells (data not shown), probably by glycolysis, suggesting that cell death is not a result of ATP depletion.
Further characterization of the cell death phenotype suggested that smARF activates autophagy. This was first assessed by examining the localization of GFPtagged LC3 (microtubule-associated protein 1 light chain 3). Vesicular accumulation of LC3 is a marker of autophagy, as recruitment of modified LC3 to the nascent autophagic vesicle is an early event in autophagosome formation (Kabeya et al., 2000) . To this end, the GFP-tagged LC3 plasmid was coexpressed with either an irrelevant control plasmid or with DNp19 ARF or TNFR-1 plasmids. Diffuse cytoplasmic localization of GFP-LC3 was observed when it was expressed together with the control or with the TNFR-1 plasmids, whereas around 60% of the cells that expressed smARF showed punctate fluorescent staining indicative of autophagic vesicles ( Figure 6D) . Furthermore, the number of autophagic cells showing punctate staining of LC3 was not significantly reduced upon administration of the pancaspase inhibitor zVAD-fmk ( Figure 6E ). The presence of autophagic vesicles was further confirmed by examination of 293T transfectants by transmission EM (TEM). As expected, in control-transfected cells, autophagic vesicles were rarely observed (Figure 6Fa ). In contrast, numerous double membrane-enclosed vesicles surrounding cytoplasmic matter and organelles appeared in DNp19 ARF -transfected cells (Figures 6Fb-6Fg) . To determine the relative kinetics with which the different smARF-induced events occurred, 293T cells were cotransfected with DNp19 ARF together with GFP-LC3 and were stained with MitoTracker Red at the indicated times. Most of the cells (96%) exhibited reduced DJm as early as 24 hr after transfection ( Figure 6G ). In contrast, autophagic vesicles accumulated more slowly. Punctate localization of GFP-LC3 was first observed at 24 hr in 47% of the cells and reached a value of 61% after 48 hr ( Figure 6G) . Thus, the disruption of DJm clearly precedes the development of autophagy in smARFexpressing cells.
Knockdown of Endogenous Autophagic Proteins
Protects against smARF-Induced Cell Death Recent studies have documented several scenarios in which induction of autophagy triggers cell death (Mills et al., 2004; Shimizu et al., 2004; Yu et al., 2004) while in many other cellular settings autophagy is cytoprotective (reviewed by Gozuacik and Kimchi [2004] ). To assess the involvement of autophagy in smARF-induced cell death, shRNA plasmids were generated to target two key mediators of autophagosome formation, ATG5 and Beclin-1. ATG5 is part of a ubiquitin-like pathway necessary for the formation of the autophagic vesicle. It is covalently conjugated to ATG12, enabling the formation of a large multiprotein complex that is recruited to the nascent autophagosomal membrane (Mizushima et al., 2001) . Beclin-1 is a regulator of a class III phosphatidylinositol 3-kinase complex, which is involved in the nucleation of the autophagosomes (Liang et al., 1999) . Both ATG5 and Beclin-1 protein levels were partially reduced upon transfection with the shRNA constructs ( Figure 7A ). The reduction in protein expression was functionally significant since, as expected, the ATG5 or Beclin-1 shRNAs partially reduced autophagosome formation by amino acid deprivation ( Figure 7B ). To assess the effect of ATG5 or Beclin-1 reductions on smARF-induced autophagy, 293T cells in which ATG5 or Beclin-1 was knocked down were cotransfected with GFP-LC3 and DNp19
ARF . It was found that the extent of autophagy induced by smARF was partially reduced by knocking down either ATG5 or Beclin-1 in a statistically significant manner ( Figure 7C ). To determine whether autophagy is causative to the smARF-induced cell death, or is rather a cytoprotective mechanism, we measured the outcome of knockdown of ATG5 or Beclin-1 on cell viability. To this end, 293-Luc cells in which ATG5 or Beclin-1 protein levels were reduced by the shRNA plasmids were subsequently transfected with control or DNp19 ARF plasmids, and the survival assay was performed 72 hr later. It was found that the knockdown of the autophagic proteins attenuated rather than increased the ability of smARF to induce cell death ( Figure 7D ). This result was obtained repeatedly in three independent experiments. Western blotting confirmed that equal levels of smARF were expressed in all transfectants ( Figure 7A) . Thus, the massive autophagy that is induced by smARF positively contributes to the cell death process. uncharacterized translation product, smARF, which results from internal initiation at Met45. This form lacks the N-terminal region encompassing the domains required for the various nucleolar functions of p19 ARF and, instead, translocates to a Proteinase K-resistant compartment of the mitochondria. In healthy cells, smARF accumulates to low steady-state levels, due to its rapid turnover, and thus is not harmful to cells. Forced expression of this form, however, leads to dissipation of the DJm and ultimately to autophagic vesicle formation and caspase-independent cell death.
smARF causes the dissipation of the inner membrane potential by a mechanism that does not involve the different Bcl-2 family members that were examined. Furthermore, no signs of cytochrome c release into the cytoplasm and subsequent caspase activation were detected, suggesting that the outer membrane is not damaged by smARF. Thus smARF does not trigger type I caspase-dependent cell death. Instead, smARF induced the formation of autophagosomes. Autophagy can be used by cells to protect them from adverse conditions or alternatively may lead to their final destruction (reviewed by Gozuacik and Kimchi [2004] ). The electron microscopy studies performed here showed that smARF induces a large number of autophagosomes in cells, which engulf different intracellular components including mitochondria, ER, and bulk cytoplasm. Knocking down two important elements in the autophagy pathways, ATG5 and Beclin-1, partially compromised both autophagic activity and cell death, implying that autophagy is necessary for smARF-induced cell death. Several studies suggest that damaged mitochondria may be a trigger for the induction of autophagy (Elmore et al., 2001; Rodriguez-Enriquez et al., 2004) . In particular, in yeast grown under nonstarvation conditions, autophagy can be induced by impairing the mitochondrial electrochemical transmembrane potential (Priault et al., 2005) . Thus, it is possible, although not yet proven, that the smARF-induced mitochondrial depolarization may signal the induction of autophagic vesicle formation. Since ATP levels were not reduced in smARF-expressing cells, it is unlikely that the signaling operates through induction of AMP kinase (AMPK) and mTOR inhibition.
Ectopic expression of cellular and viral oncogenes led to elevation of smARF protein levels, suggesting that both the nucleolar full-length p19 ARF and the mitochondrial short form are regulated by oncogenes. The existence of these two isoforms of p19 ARF may thus enable hyperproliferative signals to activate two concurrent pathways that may both contribute to the cell's defensive response to transformation. The first pathway involves the known nucleolar functions of the full-length protein, i.e., regulation of p53 stability and activity by binding to Mdm2 (Honda and Yasuda, 1999; Midgley et al., 2000; Tao and Levine, 1999; Weber et al., 1999) and interference with the processing and maturation of preribosomal RNA, thereby restraining protein synthesis and cell growth Itahana et al., 2003; Sugimoto et al., 2003) . The second pathway, activated by the short form, utilizes a mitochondria-based mechanism to induce autophagy and caspase-independent cell death. This mitochondrial pathway may act as a back-up to the nuclear pathway, particularly in circumstances when p53 and/or the caspase-dependent apoptotic pathway are nonfunctional.
It is noteworthy that in response to DNA damage, a fraction of p53 may also localize to the mitochondria and activate a mitochondrial-based death pathway, yet by a different mechanism that involves Bcl-2 family members (Mihara et al., 2003) . Furthermore, p53 was recently linked to autophagy by activating AMPK and inhibiting mTOR activity upon glucose deprivation and is also a target for activation by AMPK (Feng et al., 2005; Jones et al., 2005) . However, those mechanisms do not appear to bear any relationship to the ARF activity described in the present study.
Notably, the human p14 ARF ortholog is also capable of producing hsmARF, which can localize to and impair the mitochondria, despite its retention of a second nucleolar localization signal (Weber et al., 2000b) . Thus the mitochondrial function of ARF is conserved between the disparate human and mouse orthologs. A comparison of sequence databases revealed, however, that while the human, mouse, and hamster genes all have a second Met at a similar position, there is no corresponding Met in the published sequences from other species such as rat, opossum, and pig. Yet, expression of the cDNA for rat p19 ARF produced a shorter form of the protein in the presence of proteasome inhibition, similar to what was observed for the human protein. Thus, while it is likely that the rat ortholog utilizes another mechanism to generate its short form, the production of smARF is conserved among mammals, suggesting that this form serves an essential cellular function.
In summary, an already complex picture involving the existence of alternative reading frames of the INK4A/ ARF locus has now become even more exciting with the discovery of an alternative translation product of the ARF mRNA. The interesting activities associated with this short ARF isoform may in fact be critical to ARF's tumor suppressor function.
Experimental Procedures DNA Constructs, Transfections, and Infections All cell lines were grown as previously described (Cohen et al., 1997; Raveh et al., 2001 ). 293T and HeLa cells were transiently transfected by the standard calcium phosphate technique. NIH3T3 cells, 35-8 cells, and Bax/Bak double knockout immortalized MEFs were transiently transfected with Lipofectamine (Invitrogen). Retroviral mediated infections were performed as previously described (Cohen et al., 1997; Raveh et al., 2001) . To induce autophagy by amino acid deprivation, cells were washed twice with PBS and then incubated in Earle's balanced salt solution (EBSS, Biological Industries) for 3 hr at 37ºC. p19 ARF and p14 ARF were expressed from pcDNA3 plasmids tagged at their C terminus with the Flag epitope. Methionine substitution mutants were generated by site-directed mutagenesis (QuikChange Site-Directed Mutagenesis Kit, Stratagene). Rat p19 ARF was cloned from a rat bladder cDNA library (kind gift of N. Dekel, Weizmann Institute of Science) by PCR using primers corresponding to accession number AY679727, with a Flag tag at the 3 0 end of the cDNA. To generate pSUPER-based shRNA vectors targeting Beclin-1, ATG5, and HcRed (control), 19-mer oligos corresponding to nucleotides 1339-1357 of Beclin-1 (accession number NM003766), 779-797 of ATG5 (accession number NM004849) (Boya et al., 2005) , and 99-117 of HcRed (accession number AF363776) were annealed and ligated into the BglII and HindIII of the pSUPER vector (Brummelkamp et al., 2002) . Myc and E2F-1 were produced from pBabe-puro-derived retroviruses that were used to infect cells under puromycin selection conditions as previously described (Raveh et al., 2001) . Cells were viewed live on an inverted IX70 microscope (Olympus) equipped with a CPlan 103 objective (N.A. 0.25) and a DVC digital camera (Digital Video Camera Co.). Images were captured using the C-View V2.1 imaging program and processed with Adobe Photoshop.
Protein Analysis
Cell lysis, immunoprecipitations, and immunoblotting were done as previously described (Raveh et al., 2001 ). Proteins were separated on 10%, 12%, or 15% SDS-PAGE. The following monoclonal antibodies were used: anti Flag, anti a-tubulin, and anti actin (Sigma); anti c-Myc, anti E2F-1, and anti Bcl-2 (Santa Cruz Biotechnology); anti cytochrome c (BD Biosciences); and anti PARP (BIOMOL). Polyclonal antibodies to p19 ARF (Abcam); mitochondrial HSP70/GRP75, Bcl-XL, and Beclin-1 (Santa Cruz Biotechnology); cleaved caspase-3 (Cell Signaling); and ATG5 (a generous gift from N. Mizushima) were used. Detection was done by either HRP-conjugated goat anti-mouse or anti-rabbit secondary antibodies (Jackson ImmunoResearch), followed by enhanced chemiluminescence (SuperSignal, Pierce)
In Vitro Transcription and Translation Assay  Wt p19   ARF   , p19 ARF mutant, wt p14 ARF , and p14 ARF mutant plasmids were used as templates for coupled in vitro transcription/translation from the T7 promoter (TNT Reticulocyte Lysate Systems, Promega) by conventional procedures, using a complete amino acid mixture. The reaction products were immunoprecipitated with M2-Flag beads and then subjected to Western blot analysis on 12% or, where indicated, 15% gels.
Analysis of Protein Stability In Vivo
The turnover of the endogenous smARF in 35-8 cells was monitored by Western blot analysis of cell extracts following the addition of 20 mg/ml cycloheximide (Sigma). In addition, when indicated, the proteasome inhibitor MG132 (Calbiochem; 10 mM or 100 mM) was included.
Cell Fractionation and Proteinase K Sensitivity Assays Cell pellets were suspended in isotonic HIM buffer (200 mM mannitol, 70 mM sucrose, 1 mM EGTA, 10 mM HEPES [pH 7.5]) with protease inhibitors, incubated 10 min on ice, homogenized by multiple passages through a 25G needle, and centrifuged at 300 3 g at 4ºC for 10 min to pellet the nuclear fraction. To reduce the amount of unlysed cells in the nuclear fraction, the homogenization procedure was repeated twice in the nuclear fraction. The final pellets were extracted with PLB buffer containing protease inhibitors (nuclear fraction). The supernatant (S1) was recentrifuged at 10,000 3 g at 4ºC for 10 min to pellet mitochondria, and the supernatant was saved as the cytosolic fraction. Unless indicated otherwise, the crude mitochondria fraction was resuspended in HIM buffer and treated for 30 min with Proteinase K (0.1 or 1 mg/ml) in the presence or absence of Triton X-100 (1% final concentration). Proteolysis was stopped by the addition of 5 nM PMSF. The mitochondrial pellets were extracted with PLB buffer containing protease inhibitors to give the mitochondrial fraction.
Immunostaining
Wt p19
ARF and derived mutants were transfected into HeLa, NIH3T3, 35-8, 293T cells, or Bax/Bak double knockout MEFs grown on glass coverslips. When indicated, after 24 hr the cells were treated with 100 nM MitoTracker dye (CMX-Ros, Molecular Probes) in growth medium for 30 min at 37ºC and then fixed and permeabilized by subsequent incubations in 3.7% formaldehyde, methanol, and acetone. Cells were then permeabilized/blocked with 0.4% Triton-X 100 (Sigma) in 10% normal goat serum (Biological Industries) and incubated for 1 hr with mouse anti-Flag antibodies (Sigma), followed by FITC-conjugated donkey anti-mouse secondary antibodies (Jackson ImmunoResearch) or rabbit polyclonal anti-Flag (Sigma), followed by rhodamine-RedX (RRX)-conjugated goat anti-rabbit (Jackson ImmunoResearch). To stain endogenous p19 ARF , 35-8 cells and NIH3T3 cells were permeabilized with 0.5% Triton-X-100 in 4% paraformaldehyde solution for 5 min and then fixed with paraformaldehyde for 20 min. Cells were incubated with antibodies to p19 ARF (Abcam) or cytochrome c (BD Biosciences) and then incubated with Cy-2-conjugated donkey anti-rabbit antibodies or Rhodamine-conjugated goat anti-mouse antibodies (Jackson ImmunoResearch). Cells were finally stained with DAPI (0.5 mg/ml, Sigma). To visualize autophagosomes, 293T cells grown on glass coverslips in the presence or absence of 100 mM zVAD-fmk (Sigma) were cotransfected with 1 mg GFP-LC3 and 9 mg luciferase, DNp19 ARF , or TNFR-1 expression plasmids. Stained cells were viewed by fluorescent microscopy (Olympus BX41) with 603 (N.A. 1.25) or 1003 (N.A. 1.3) UPlan-Fl oil immersion objectives, and digital images were obtained with a DP50 CCD camera using ViewfinderLite and StudioLite software (Olympus). Composites and merged images were generated in Photoshop (Adobe Systems).
Flow Cytometric Analysis of DJm
Perturbations in DJm were monitored by flow cytometry. Transfected NIH3T3 cells were collected in culture medium by trypsinization and stained with 40 nM 3,3 0 dihexyloxacarbocyanine (DiOC 6 , Sigma) for 30 min at 37ºC. Samples were then analyzed by a FACScan cytometer (Becton Dickinson), using an excitation laser of 488 nm and emission filter of 530/30 nm.
Viability Assays
For the Neutral Red assay, 293T cells were transfected with control (CAT), DNp19
ARF , or TNFR-1 plasmids, and cell viability was measured via the uptake of the vital dye Neutral Red (Sigma) according to the manufacturer's instructions. For the luciferase-based survival assay, a monoclonal population of 293 cells stably transfected with pcDNA3-luciferase was generated by G418 selection (293-Luc). 293-Luc cells were then transfected with control (CAT), DNp19
ARF , or TNFR-1 plasmids. For some experiments, cells were transfected 2 days in advance with shRNA plasmids. Cell viability was assessed by measuring luciferase activity (Promega) according to the manufacturer's instructions, using an Anthos Lucy3 Microplate Luminometer. The overall cell survival in the shRNA experiments was determined by dividing the mean luciferase activity (from triplicates) of cells transfected with DNp19
ARF by the mean activity of cells transfected with control (CAT) for each knockdown experiment. For trypan blue staining, 293T cells were transfected with control (CAT), DNp19 ARF , or TNFR-1 plasmids, and cell death was measured by uptake of trypan blue (Sigma) into cells that had lost membrane integrity.
Transmission Electron Microscope 293T cells were transfected with luciferase (control) or DNp19 ARF plasmids. Cells were fixed for 1 hr in Karnovsky's fixative (3% paraformaldehyde, 2% glutaraldehyde, 5 mM CaCl 2 in 0.1 M cacodylate buffer [pH 7.4], containing 0.1 M sucrose). Cells were scraped, pelleted, and embedded with agar noble to a final concentration of 1.7% and postfixed with 1% OsO 4 , 0.5% potassium dichromate, and 0.5% potassium hexacyanoferrate in 0.1 M cacodylate buffer. The pellet was stained en bloc with 2% aqueous uranyl acetate followed by ethanol dehydration and embedded in EMbed (EMS). Sections (75 nm) were cut, stained with 2% uranyl acetate in 50% ethanol and lead citrate, and examined using a FEI CM12 EINDHOVEN transmission electron microscope at an accelerating voltage of 120 kV. Digital images were obtained with MegaView3 CCD camera (SIS GMBH).
